Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors

Autor: Stefan Zschiedrich, Nicole Reisch, Ursula Ploeckinger, Joanne Ngeow, Raymond H. Kim, William F. Young, Dmitry Beltsevich, Francesca Schiavi, Umit Ugurlu, Madson Q. Almeida, Taweesak Wannachalee, Gabriela Sanso, Mònica Recasens, Angelica Malinoc, Roman Petrov, Luis Robles Diaz, Andrzej Januszewicz, Jochen Seufert, Holger Amthauer, Svetlana Yaremchuk, Karl-Heinrich Link, Ulrich F. Wellner, Timm Denecke, Jens Aberle, Nalini S. Shah, Xiao-Ping Qi, Marina Y. Yukina, Zheiwei Zhang, Ernst von Dobschuetz, Marta Barontini, Maria Candida Barisson Villares Fragoso, Andrey Kvachenyuk, Laura von Duecker, Giuseppe Opocher, Swati S Jadhav, Roland Därr, Birke Bausch, Merav Fraenkel, Viacheslav I. Egorov, Staffan Welin, Özer Makay, Sirinart Sirinvaravong, Rene Eduardo Diaz, Garrett Bullivant, Matthias Schott, Ana Rosa Pinto Quidute, Ekaterina Kuchinskaya, Camilla Schalin-Jäntti, Charis Eng, Martin K. Walz, Ana O. Hoff, Barbara Jarzab, Tobias B. Huber, Thera P. Links, Nikolaus Tiling, Kornelia Hasse-Lazar, Eric Jonasch, Gianmaria Pennelli, Per Hellman, Maria Adelaide Albergaria Pereira, Nelson Wohllk, Tada Kunavisarut, Attila Patócs, Dirk Bausch, Juri Ruf, Hartmut P. H. Neumann, Alice Helena Dutra Violante, Simona Grozinsky-Glasberg, Stefania Zovato, Oliver Gimm, Alfonso Massimiliano Ferrara, Delmar Munir Lourenço, Mariola Pęczkowska, Marija Pfeifer, Irina Bancos, Tobias Krauss, Karina Villar Gómez de las Heras

Publikováno v: Endocrine-Related cancer, 25(9), 783-793. BIOSCIENTIFICA LTD

Pancreatic neuroendocrine tumors (PanNETs) are rare in von Hippel–Lindau disease (VHL) but cause serious morbidity and mortality. Management guidelines for VHL-PanNETs continue to be based on limited evidence, and survival data to guide surgical ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f5b8eb7e6a170cf36d257d35ee3d86
https://doi.org/10.1530/erc-18-0100